Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Optimer heading for clinical evaluation with new C. difficile-selective antibiotic

Oct. 8, 2003

Resubmitted NDA for Helicide deemed not approvable

Oct. 8, 2003

New MMP inhibitors and their use reported by British Biotech and Serono researchers

Oct. 7, 2003

Forest discontinues development of dexloxiglumide for constipation-predominant IBS

Oct. 6, 2003

APAZA completes first phase I trial

Oct. 3, 2003

New phase III trial evaluates Humira for Crohn's disease

Oct. 1, 2003

NIAID grant supports development of RNAi approach for hepatitis B treatment

Oct. 1, 2003

Argenta identifies candidate series in Pharmagene IBS collaboration

Oct. 1, 2003

Major study to directly compare PEG-Intron and Pegasys for HCV

Sep. 30, 2003

Boehringer Ingelheim presents new HCV NS3 inhibitors

Sep. 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...